GNOMvsXHEETF Comparison
Global X Genomics & Biotechnology ETF (GNOM) belongs to the BioTech & Genomics segment. State Street SPDR S&P Health Care Equipment ETF (XHE) is part of the US Health Care segment. In contrast, XHE's top sector exposures are Healthcare and Finance. GNOM is more expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.35% for XHE. GNOM is up 36.95% year-to-date (YTD) with +$21M in YTD flows. XHE performs worse with 2.14% YTD performance, and +$11M in YTD flows. Run a side-by-side ETF comparison of GNOM and XHE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
GNOM vs XHE performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM XHE | +4.57%-5.10% | +27.28%+9.79% | +36.95%+2.14% | +69.95%+9.32% | +43.87%+7.53% | -32.85%-30.21% |
| Flows | GNOM XHE | +$2M+$3M | +$18M+$12M | +$21M+$11M | +$15M-$245K | -$54M-$266M | -$42M-$382M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM XHE | +37.85%+24.14% | +30.56%+22.69% | +30.36%+22.22% | +33.83%+24.84% |
| Max drawdown | GNOM XHE | -8.57%-7.53% | -18.16%-18.20% | -43.10%-24.35% | -71.04%-49.37% |
| Max drawdown duration | GNOM XHE | 32d23d | 145d207d | 674d565d | 1818d1773d |
GNOM | XHE | |
Last sale 9/14/2026 at 1:30 PM | $63.57 | $91.43 |
| Previous close 09/11/2026 | $62.22 | $90.01 |
| Consolidated volume 09/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GNOM | XHE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GNOM | XHE | |
|---|---|---|
| Last price | $63.57 | $91.43 |
| 1D performance | +2.17% | +1.58% |
| AuM | $93.74 M | $168.78 M |
| E/R | 0.5% | 0.35% |
GNOM | XHE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Global X | State Street Investment Management |
| Benchmark | Solactive Genomics Index | S&P Health Care Equipment Select Industry Index |
| N° of holdings | - | 66 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | January 26, 2011 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
